Board Committee Changes

RNS Number : 2739D

GlaxoSmithKline PLC

27 January 2015

GlaxoSmithKline plc (the "Company")

Board Committee changes

GSK announces that Sir Philip Hampton has been appointed Chairman of the Nominations Committee (the "Committee") with effect from today, replacing Sir Christopher Gent, who will continue to serve as a member of the Committee for the remainder of his tenure on the Board.

In addition, Ms Lynn Elsenhans has also been appointed a member of the Committee, effective today.

The membership of the Nominations Committee is now:

Committee Chairman	Sir Philip Hampton	Chairman Designate
Members	Sir Christopher Gent	Chairman
	Professor Sir Roy Anderson	Scientific & Medical Expert
	Lynn Elsenhans	Independent Non Executive Director
	Judy Lewent	Audit & Risk Committee Chairman
	Sir Deryck Maughan	Senior Independent Director
	Tom de Swaan	Remuneration Committee Chairman